HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Yong Hwang Selected Research

Heart Failure

4/2024Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction.
6/2019The clinical impact of sex differences on ischemic postconditioning during primary percutaneous coronary intervention: a POST (the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction) substudy.
2/2019Clinical efficacy of high-flow oxygen therapy through nasal cannula in patients with acute heart failure.
1/2019Erratum to clinical efficacy of high-flow oxygen therapy through nasal cannula in patients with acute heart failure.
1/2018Prognostic value of total triiodothyronine and free thyroxine levels for the heart failure in patients with acute myocardial infarction.
12/2017Prognostic value of brachial-ankle pulse wave velocity in patients with non-ST-elevation myocardial infarction.
5/2015Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trial.
10/2013Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Yong Hwang Research Topics

Disease

29Myocardial Infarction
04/2024 - 02/2010
11ST Elevation Myocardial Infarction
01/2023 - 10/2010
9Hemorrhage
06/2023 - 01/2012
8Heart Failure
04/2024 - 10/2013
8Thrombosis (Thrombus)
04/2024 - 01/2012
7Death (Near-Death Experience)
04/2024 - 01/2012
5Infarction (Infarctions)
04/2024 - 11/2011
5Stroke (Strokes)
06/2023 - 12/2017
5Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 10/2013
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 11/2013
3Non-ST Elevated Myocardial Infarction
04/2024 - 12/2017
3Inflammation (Inflammations)
06/2023 - 09/2013
3Pathologic Constriction (Stenosis)
11/2020 - 08/2004
3Neoplasms (Cancer)
10/2018 - 05/2007
2Essential Hypertension
05/2024 - 01/2023
2Ischemic Stroke
01/2022 - 05/2017
2Acute Coronary Syndrome
01/2022 - 10/2021
2Body Weight (Weight, Body)
10/2021 - 01/2021
2Ventricular Remodeling
10/2020 - 11/2011
2Heart Arrest (Cardiac Arrest)
11/2018 - 06/2018
2Embolism (Embolus)
11/2018 - 06/2018
2Sarcoma (Soft Tissue Sarcoma)
11/2018 - 06/2018
2Fibrosis (Cirrhosis)
01/2016 - 12/2015
2Atherosclerotic Plaque (Atheroma)
07/2009 - 11/2004
2Atherosclerosis
07/2009 - 11/2004
1Cardiogenic Shock
04/2024
1Dizziness (Lightheadedness)
04/2024
1Pain (Aches)
04/2024
1Headache (Headaches)
04/2024
1Dyspnea (Shortness of Breath)
01/2022
1Fabry Disease (Fabry's Disease)
06/2021
1Peripheral Arterial Disease
11/2020
1Reperfusion Injury
10/2020
1Respiratory Insufficiency (Respiratory Failure)
02/2019
1Atrial Fibrillation
05/2017
1Chest Pain (Chest Pains)
01/2017
1Left Ventricular Outflow Obstruction
01/2017
1Cardiac Tamponade
01/2017
1Coronary Stenosis (Coronary Artery Stenosis)
09/2016

Drug/Important Bio-Agent (IBA)

14Clopidogrel (Plavix)FDA Link
01/2022 - 02/2010
8omega-Chloroacetophenone (Mace)IBA
04/2024 - 11/2013
8Cilostazol (Pletal)FDA LinkGeneric
04/2024 - 02/2010
6Cytochrome P-450 CYP2C19IBA
11/2012 - 07/2010
3Amlodipine (Norvasc)FDA LinkGeneric
05/2024 - 02/2019
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2023 - 11/2011
3Angiotensin Receptor AntagonistsIBA
01/2023 - 11/2011
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022 - 01/2016
3TicagrelorIBA
01/2022 - 10/2020
3CalciumIBA
11/2018 - 02/2013
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2017 - 12/2011
2Brain Natriuretic Peptide (Natrecor)FDA Link
04/2024 - 01/2022
2C-Reactive ProteinIBA
06/2023 - 11/2020
2Antihypertensive Agents (Antihypertensives)IBA
01/2023 - 04/2017
2CholesterolIBA
10/2021 - 09/2013
2Oxygen (Dioxygen)IBA
02/2019 - 01/2019
2LigandsIBA
10/2018 - 07/2009
2Valsartan (Vals)FDA Link
01/2018 - 11/2011
2Adenosine Diphosphate (ADP)IBA
01/2016 - 01/2012
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2016 - 05/2007
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2012 - 04/2011
2CytochromesIBA
04/2012 - 07/2010
2GlycosaminoglycansIBA
12/2008 - 11/2004
2BiglycanIBA
12/2008 - 11/2004
1IrbesartanFDA LinkGeneric
05/2024
1pro-brain natriuretic peptide (1-76)IBA
04/2024
1Indicators and Reagents (Reagents)IBA
06/2023
1NucleotidesIBA
02/2023
1Chlorthalidone (Chlortalidone)FDA LinkGeneric
01/2023
1Telmisartan (Micardis)FDA Link
01/2023
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1Prasugrel HydrochlorideFDA Link
10/2021
1Triglycerides (Triacylglycerol)IBA
10/2021
1GlycosphingolipidsIBA
06/2021
1GalactosidasesIBA
06/2021
1EnzymesIBA
06/2021
1Phenobarbital (Luminal)FDA Link
11/2020
1FibrinIBA
11/2020
1ThrombinFDA Link
11/2020
1Dihydrotachysterol (AT 10)IBA
10/2020
1erucylphosphocholineIBA
06/2020
1AcidsIBA
01/2020
1Proton Pump InhibitorsIBA
01/2020
1Death Domain ReceptorsIBA
10/2018
1pembrolizumabIBA
10/2018
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2018
1Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2018
1Ergonovine (Ergometrine)IBA
01/2017
1GW 610742IBA
01/2016
1Transforming Growth Factor beta (TGF-beta)IBA
01/2016
1Therapeutic UsesIBA
01/2016
1Dacarbazine (DIC)FDA LinkGeneric
12/2015

Therapy/Procedure

26Percutaneous Coronary Intervention
04/2024 - 11/2012
13Therapeutics
05/2024 - 02/2010
8Stents
04/2024 - 08/2004
4Ischemic Postconditioning
06/2019 - 10/2013
2Cannula
02/2019 - 01/2019
2Thrombectomy
11/2018 - 06/2018
1Immunotherapy
10/2018
1Drug Therapy (Chemotherapy)
10/2018
1Radiotherapy
10/2018